Due to increasing demand for acne treatments, the Prescription Acne Treatment Manufacturing industry has exhibited positive growth during the five years to 2013. Because acne-prone individuals consider treatment products a necessary expense, revenue continued to rise despite the recession, though growth did slow as consumers switched to more inexpensive products like over-the-counter (OTC) acne treatments. In the next five years, the industry will benefit from improving economic conditions, as disposable income growth allows consumers to spend on higher-priced items. Furthermore, companies are expected to increasingly develop product lines with all-natural ingredients, given changing consumer preferences.
Companies in this industry are engaged in manufacturing prescription medications to control acne.
The report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecast, growth rates and an analysis of the industry key players and their market shares.